Pay in 4 interest-free payments of $6.66 Learn more
Ships within 48 hours · Estimated delivery Aug 26 - Aug 31
The picture is complicated by several confounding factors: Weight loss itself is associated with improved mood and reduced depressive symptoms in many individuals Better glycaemic control may enhance overall wellbeing and reduce diabetes-related distress Selection bias may exist, as patients with severe mental health conditions might be less likely to be prescribed these medications initially Currently, there is no official indication for GLP-1 agonists in treating depression, and the MHRA has not licensed these medications for mental health conditions
Our study also indicates that liver-targeted TR agonists could be tested for the treatment of type 2 diabetes in the future
That means building habits that support your overall health
Supplements and topical actives are meant to enhance a lifestyle built on solid health foundations, not replace them
